메뉴 건너뛰기
Journal of Neurology
Volumn 260, Issue 1, 2013, Pages 327-329
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients
Author keywords

[No Author keywords available]
Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; ETIRACETAM; FINGOLIMOD; GADOLINIUM; GLATIRAMER; METHYLPREDNISOLONE; NATALIZUMAB; PLACEBO;
EID: 84872316838     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6744-7     Document Type: Letter
Times cited : (34)
References (9)
  • 1
    • 84856912473 scopus 로고    scopus 로고
    • Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment
    • 22332194 10.1001/archneurol.2011.1057
    • Havla JB, Pellkofer HL, Meinl I et al (2012) Rebound of disease activity after withdrawal of fingolimod (FTY720) treatment. Arch Neurol 69:262-264
    • (2012) Arch Neurol , vol.69 , pp. 262-264
    • Havla, J.B.1    Pellkofer, H.L.2    Meinl, I.3
  • 2
    • 84868026062 scopus 로고    scopus 로고
    • Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: Report of six cases
    • doi: 10.1177/1352458512454773
    • Hakiki B, Portaccio E, Giannini M et al (2012) Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases. Mult Scler. doi: 10.1177/1352458512454773
    • (2012) Mult Scler.
    • Hakiki, B.1    Portaccio, E.2    Giannini, M.3
  • 3
    • 84871187559 scopus 로고    scopus 로고
    • Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod
    • Epub ahead of print
    • Gross CM, Baumgartner A, Rauer S, Stich O (2012) Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod. Neurology. [Epub ahead of print]
    • (2012) Neurology.
    • Gross, C.M.1    Baumgartner, A.2    Rauer, S.3    Stich, O.4
  • 4
    • 76149093586 scopus 로고    scopus 로고
    • A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis
    • 20089952 10.1056/NEJMoa0909494 1:CAS:528:DC%2BC3cXhvVWltr4%3D
    • Kappos L, Radue EW, O'Connor P et al (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 362:387-401
    • (2010) N Engl J Med , vol.362 , pp. 387-401
    • Kappos, L.1    Radue, E.W.2    O'Connor, P.3
  • 5
    • 76149140914 scopus 로고    scopus 로고
    • Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
    • 20089954 10.1056/NEJMoa0907839 1:CAS:528:DC%2BC3cXhvVWrsbk%3D
    • Cohen JA, Barkhof F, Comi G et al (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362:402-415
    • (2010) N Engl J Med , vol.362 , pp. 402-415
    • Cohen, J.A.1    Barkhof, F.2    Comi, G.3
  • 6
    • 33644974688 scopus 로고    scopus 로고
    • Secondary progressive multiple sclerosis: Current knowledge and future challenges
    • 16545751 10.1016/S1474-4422(06)70410-0
    • Rovaris M, Confavreux C, Furlan R et al (2006) Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol 5:343-354
    • (2006) Lancet Neurol , vol.5 , pp. 343-354
    • Rovaris, M.1    Confavreux, C.2    Furlan, R.3
  • 7
    • 79951543155 scopus 로고    scopus 로고
    • Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy
    • 20937940 10.1001/archneurol.2010.257
    • Miravalle A, Jensen R, Kinkel P (2011) Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy. Arch Neurol 68(2):186-191
    • (2011) Arch Neurol , vol.68 , Issue.2 , pp. 186-191
    • Miravalle, A.1    Jensen, R.2    Kinkel, P.3
  • 8
    • 84856209651 scopus 로고    scopus 로고
    • Fingolimod in multiple sclerosis: Mechanisms of action and clinical efficacy
    • 10.1016/j.clim.2011.05.005 21669553
    • Ingwersen J, Aktas O, Kuery P et al (2011) Fingolimod in multiple sclerosis: mechanisms of action and clinical efficacy. Clin Immunol. doi: 10.1016/j.clim.2011.05.005
    • (2011) Clin Immunol
    • Ingwersen, J.1    Aktas, O.2    Kuery, P.3
  • 9
    • 0026506799 scopus 로고
    • Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha4beta1 integrin
    • 1538783 10.1038/356063a0 1:CAS:528:DyaK38Xhslaisbw%3D
    • Yednock TA, Cannon C, Fritz LC et al (1992) Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha4beta1 integrin. Nature 356:63-66
    • (1992) Nature , vol.356 , pp. 63-66
    • Yednock, T.A.1    Cannon, C.2    Fritz, L.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.